Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 2
2010 1
2011 2
2012 4
2013 4
2014 1
2015 3
2016 1
2017 3
2018 3
2019 1
2020 5
2021 12
2022 7
2023 6
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. Among authors: ulys a. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Enzalutamide in metastatic prostate cancer before chemotherapy.
Beer TM, Armstrong AJ, Rathkopf DE, Loriot Y, Sternberg CN, Higano CS, Iversen P, Bhattacharya S, Carles J, Chowdhury S, Davis ID, de Bono JS, Evans CP, Fizazi K, Joshua AM, Kim CS, Kimura G, Mainwaring P, Mansbach H, Miller K, Noonberg SB, Perabo F, Phung D, Saad F, Scher HI, Taplin ME, Venner PM, Tombal B; PREVAIL Investigators. Beer TM, et al. N Engl J Med. 2014 Jul 31;371(5):424-33. doi: 10.1056/NEJMoa1405095. Epub 2014 Jun 1. N Engl J Med. 2014. PMID: 24881730 Free PMC article. Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. Among authors: ulys a. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial.
Saad F, Vjaters E, Shore N, Olmos D, Xing N, Pereira de Santana Gomes AJ, Cesar de Andrade Mota A, Salman P, Jievaltas M, Ulys A, Jakubovskis M, Kopyltsov E, Han W, Nevalaita L, Testa I, Le Berre MA, Kuss I, Haresh KP; ARANOTE Study Investigators. Saad F, et al. Among authors: ulys a. J Clin Oncol. 2024 Sep 16:JCO2401798. doi: 10.1200/JCO-24-01798. Online ahead of print. J Clin Oncol. 2024. PMID: 39279580
Liproca Depot: A New Antiandrogen Treatment for Active Surveillance Patients.
Klotz L, Grudén S, Axén N, Gauffin C, Wassberg C, Bjartell A, Giddens J, Incze P, Jansz K, Jievaltas M, Rendon R, Richard PO, Ulys A, Tammela TL. Klotz L, et al. Among authors: ulys a. Eur Urol Focus. 2022 Jan;8(1):112-120. doi: 10.1016/j.euf.2021.02.003. Epub 2021 Feb 12. Eur Urol Focus. 2022. PMID: 33583762 Free article. Clinical Trial.
Reply by Authors.
Stuopelyte K, Sabaliauskaite R, Bakavicius A, Haflidadóttir BS, Visakorpi T, Väänänen RM, Patel C, Danila DC, Lilja H, Lazutka JR, Ulys A, Jankevicius F, Jarmalaite S. Stuopelyte K, et al. Among authors: ulys a. J Urol. 2020 Jul;204(1):77-78. doi: 10.1097/JU.0000000000000803.02. Epub 2020 Apr 28. J Urol. 2020. PMID: 32343215 No abstract available.
Extralobar pulmonary sequestration.
Ulys A, Samalavicius NE, Cicenas S, Petraitis T, Trakymas M, Sheinin D, Gatijatullin L. Ulys A, et al. Int Med Case Rep J. 2011 Apr 1;4:21-3. doi: 10.2147/IMCRJ.S15261. Print 2011. Int Med Case Rep J. 2011. PMID: 23754900 Free PMC article.
55 results